Followers | 6 |
Posts | 1387 |
Boards Moderated | 0 |
Alias Born | 10/08/2009 |
Friday, June 22, 2018 10:57:21 AM
============
Pursuant to Listing Rule 17.1, Clinuvel Pharmaceuticals Ltd (CUV) requests an immediate trading halt with respect to its ordinary shares listed on the ASX. The trading halt is necessary as CUV proposes to make an announcement to the market regarding a regulatory submission for its drug SCENESSE®.
CUV requests that trading in its securities be halted until after the expected announcement is made or until the commencement of trade on Tuesday 26th June 2018, whichever is the earlier.
CUV is not aware of any reason why the trading halt should not be granted by the ASX nor is it aware of any other information that is necessary to inform the market about the trading halt.
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM